Long Liang Mian Mao Lei Wu Taiyu Chen Jiahua Lyu Qifeng Wang Tao Li
10.2147/OTT.S335736
Onco Targets Ther
2021 Dec 3;14:5385-5389.
eml4-alk rearrangement sbrt alectinib lorlatinib lung squamous cell carcinoma
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/34887666/
Case Reports
PMC8652916
34887666
Efficacy and Drug Resistance Analysis of ALK Inhibitors in Combination with Stereotactic Body Radiation Therapy for Treating Lung Squamous Carcinoma Patient Harboring EML4-ALK Rearrangement
2021